Stanford researchers created an AI model that analyzes one night's sleep to predict over 100 health conditions with up to 89% accuracy.
Stanford Medicine researchers have developed an artificial intelligence model that can predict a person's risk of developing more than 100 health conditions by analyzing just one night's sleep data. The groundbreaking model, called SleepFM, achieved remarkable accuracy in forecasting diseases that could strike years down the road.
How Does Sleep Data Reveal Future Disease Risk?
The AI model was trained on nearly 600,000 hours of sleep recordings from 65,000 participants, using comprehensive sleep assessments called polysomnography. This gold-standard sleep study uses various sensors to record brain activity, heart rhythms, breathing patterns, leg movements, and eye movements throughout the night.
"We record an amazing number of signals when we study sleep," said Emmanuel Mignot, the Craig Reynolds Professor in Sleep Medicine and co-senior author of the study. "It's a kind of general physiology that we study for eight hours in a subject who's completely captive. It's very data rich."
What Diseases Can Sleep Patterns Predict?
After analyzing more than 1,000 disease categories, researchers found that 130 conditions could be predicted with reasonable accuracy from sleep data alone. The model showed particularly strong performance for several major health conditions:
- Cancer Predictions: Prostate cancer with 89% accuracy and breast cancer with 87% accuracy
- Neurological Conditions: Parkinson's disease with 89% accuracy and dementia with 85% accuracy
- Heart Disease: Heart attacks with 81% accuracy and hypertensive heart disease with 84% accuracy
- Mental Health: Various mental disorders achieved accuracy levels above 80%
The model even predicted death with 84% accuracy, demonstrating the profound connection between sleep patterns and overall health outcomes.
What Makes This AI Model Different?
SleepFM represents the first large-scale use of artificial intelligence to analyze comprehensive sleep data. The researchers developed a new training technique called "leave-one-out contrastive learning," which essentially teaches the model to understand how different body signals relate to each other during sleep.
"SleepFM is essentially learning the language of sleep," explained James Zou, associate professor of biomedical data science and co-senior author. The model incorporates multiple data streams simultaneously, including brain waves, heart rhythms, muscle activity, and breathing patterns.
What's particularly fascinating is that the most accurate disease predictions came from analyzing mismatched signals between different body systems. "The most information we got for predicting disease was by contrasting the different channels," Mignot noted. For example, a brain that appears asleep while the heart remains in an awake-like state could signal future health problems.
The research team used health records spanning up to 25 years from the Stanford Sleep Medicine Center, which was founded in 1970. This extensive follow-up period allowed researchers to verify their predictions against actual disease outcomes, with some patients tracked for over two decades.
The study, published in Nature Medicine, received funding from the National Institutes of Health and represents a significant breakthrough in predictive medicine. While the model doesn't yet explain its reasoning in plain language, researchers are developing interpretation techniques to understand exactly what sleep patterns signal future disease risk.
Next in Medical Research
→ Scientists Crack the Code: How Thousands of Genes Work Together to Cause DiseasePrevious in Medical Research
← The Weight-Loss Drug Revolution Is Here—But Not Everyone Can Get ItSource
This article was created from the following source:
More from Medical Research
A Diabetes Drug May Help Prevent Lymphedema in Breast Cancer Survivors—Here's What the Research Shows
A new systematic review found that GLP-1 receptor agonists may reduce breast cancer-related lymphedema risk, while immunomodulatory therapies showed p...
Mar 4, 2026
A Rare Genetic Disease Is Getting Its First Gene Therapy Trial in 2026—Here's What That Means
GM1 gangliosidosis, a rare genetic disorder, is moving toward its first AAV gene therapy clinical trial in 2026....
Mar 3, 2026
Can Consciousness Be Studied Like Any Other Science? One Organization Is Testing That Idea
A nonprofit organization is applying rigorous clinical trial methods to study consciousness, publishing over 670 peer-reviewed studies—but experts cau...
Mar 3, 2026